nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A5—Beclomethasone—psoriasis	0.0578	0.102	CbGbCtD
Quetiapine—CYP2D6—Hydroxyurea—psoriasis	0.0269	0.0472	CbGbCtD
Quetiapine—CYP3A7—Hydrocortisone—psoriasis	0.0246	0.0432	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0246	0.0432	CbGbCtD
Quetiapine—CYP3A7—Cyclosporine—psoriasis	0.0232	0.0408	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0232	0.0408	CbGbCtD
Quetiapine—CYP3A5—Mycophenolate mofetil—psoriasis	0.023	0.0404	CbGbCtD
Quetiapine—CYP2C19—Cholecalciferol—psoriasis	0.0214	0.0376	CbGbCtD
Quetiapine—CYP3A4—Calcitriol—psoriasis	0.0201	0.0353	CbGbCtD
Quetiapine—CYP3A5—Hydrocortisone—psoriasis	0.0185	0.0324	CbGbCtD
Quetiapine—CYP3A5—Cyclosporine—psoriasis	0.0174	0.0306	CbGbCtD
Quetiapine—CYP2D6—Cholecalciferol—psoriasis	0.0163	0.0286	CbGbCtD
Quetiapine—CYP3A4—Methoxsalen—psoriasis	0.0156	0.0274	CbGbCtD
Quetiapine—CYP3A7—Dexamethasone—psoriasis	0.0153	0.0269	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0153	0.0269	CbGbCtD
Quetiapine—ABCB1—Mycophenolate mofetil—psoriasis	0.015	0.0263	CbGbCtD
Quetiapine—CYP2C19—Prednisone—psoriasis	0.0148	0.0261	CbGbCtD
Quetiapine—CYP2C19—Cyclosporine—psoriasis	0.0141	0.0247	CbGbCtD
Quetiapine—ABCB1—Betamethasone—psoriasis	0.0128	0.0226	CbGbCtD
Quetiapine—ABCB1—Prednisolone—psoriasis	0.0127	0.0223	CbGbCtD
Quetiapine—ABCB1—Hydrocortisone—psoriasis	0.012	0.0211	CbGbCtD
Quetiapine—ABCB1—Prednisone—psoriasis	0.012	0.021	CbGbCtD
Quetiapine—CYP3A5—Dexamethasone—psoriasis	0.0115	0.0202	CbGbCtD
Quetiapine—ABCB1—Cyclosporine—psoriasis	0.0114	0.0199	CbGbCtD
Quetiapine—CYP2D6—Cyclosporine—psoriasis	0.0107	0.0188	CbGbCtD
Quetiapine—CYP3A4—Cholecalciferol—psoriasis	0.0103	0.0182	CbGbCtD
Quetiapine—CYP2C19—Dexamethasone—psoriasis	0.00926	0.0163	CbGbCtD
Quetiapine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00897	0.0158	CbGbCtD
Quetiapine—CYP3A4—Triamcinolone—psoriasis	0.00897	0.0158	CbGbCtD
Quetiapine—CYP3A4—Betamethasone—psoriasis	0.0077	0.0135	CbGbCtD
Quetiapine—CYP3A4—Prednisolone—psoriasis	0.0076	0.0133	CbGbCtD
Quetiapine—ABCB1—Dexamethasone—psoriasis	0.00747	0.0131	CbGbCtD
Quetiapine—CYP3A4—Hydrocortisone—psoriasis	0.0072	0.0126	CbGbCtD
Quetiapine—CYP3A4—Prednisone—psoriasis	0.00717	0.0126	CbGbCtD
Quetiapine—CYP2D6—Dexamethasone—psoriasis	0.00704	0.0124	CbGbCtD
Quetiapine—CYP3A4—Cyclosporine—psoriasis	0.0068	0.0119	CbGbCtD
Quetiapine—ABCB1—Methotrexate—psoriasis	0.00601	0.0106	CbGbCtD
Quetiapine—CYP3A4—Dexamethasone—psoriasis	0.00448	0.00787	CbGbCtD
Quetiapine—Myalgia—Dexamethasone—psoriasis	7.76e-05	0.000213	CcSEcCtD
Quetiapine—Myalgia—Betamethasone—psoriasis	7.76e-05	0.000213	CcSEcCtD
Quetiapine—Abdominal pain—Cyclosporine—psoriasis	7.75e-05	0.000213	CcSEcCtD
Quetiapine—Body temperature increased—Cyclosporine—psoriasis	7.75e-05	0.000213	CcSEcCtD
Quetiapine—Anxiety—Betamethasone—psoriasis	7.74e-05	0.000213	CcSEcCtD
Quetiapine—Anxiety—Dexamethasone—psoriasis	7.74e-05	0.000213	CcSEcCtD
Quetiapine—Vomiting—Mycophenolic acid—psoriasis	7.7e-05	0.000212	CcSEcCtD
Quetiapine—Discomfort—Betamethasone—psoriasis	7.67e-05	0.000211	CcSEcCtD
Quetiapine—Discomfort—Dexamethasone—psoriasis	7.67e-05	0.000211	CcSEcCtD
Quetiapine—Dyspepsia—Hydrocortisone—psoriasis	7.67e-05	0.000211	CcSEcCtD
Quetiapine—Haemoglobin—Methotrexate—psoriasis	7.66e-05	0.000211	CcSEcCtD
Quetiapine—Rash—Mycophenolic acid—psoriasis	7.64e-05	0.00021	CcSEcCtD
Quetiapine—Dermatitis—Mycophenolic acid—psoriasis	7.63e-05	0.00021	CcSEcCtD
Quetiapine—Pain—Prednisolone—psoriasis	7.63e-05	0.00021	CcSEcCtD
Quetiapine—Haemorrhage—Methotrexate—psoriasis	7.62e-05	0.000209	CcSEcCtD
Quetiapine—Hepatitis—Methotrexate—psoriasis	7.62e-05	0.000209	CcSEcCtD
Quetiapine—Headache—Mycophenolic acid—psoriasis	7.59e-05	0.000209	CcSEcCtD
Quetiapine—Decreased appetite—Hydrocortisone—psoriasis	7.57e-05	0.000208	CcSEcCtD
Quetiapine—Pharyngitis—Methotrexate—psoriasis	7.57e-05	0.000208	CcSEcCtD
Quetiapine—Body temperature increased—Mycophenolate mofetil—psoriasis	7.56e-05	0.000208	CcSEcCtD
Quetiapine—Abdominal pain—Mycophenolate mofetil—psoriasis	7.56e-05	0.000208	CcSEcCtD
Quetiapine—Urinary tract disorder—Methotrexate—psoriasis	7.53e-05	0.000207	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.52e-05	0.000207	CcSEcCtD
Quetiapine—Fatigue—Hydrocortisone—psoriasis	7.51e-05	0.000206	CcSEcCtD
Quetiapine—Vision blurred—Prednisone—psoriasis	7.48e-05	0.000206	CcSEcCtD
Quetiapine—Urethral disorder—Methotrexate—psoriasis	7.47e-05	0.000205	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.47e-05	0.000205	CcSEcCtD
Quetiapine—Pain—Hydrocortisone—psoriasis	7.45e-05	0.000205	CcSEcCtD
Quetiapine—Anaphylactic shock—Dexamethasone—psoriasis	7.44e-05	0.000204	CcSEcCtD
Quetiapine—Anaphylactic shock—Betamethasone—psoriasis	7.44e-05	0.000204	CcSEcCtD
Quetiapine—Insomnia—Triamcinolone—psoriasis	7.42e-05	0.000204	CcSEcCtD
Quetiapine—Infection—Dexamethasone—psoriasis	7.39e-05	0.000203	CcSEcCtD
Quetiapine—Infection—Betamethasone—psoriasis	7.39e-05	0.000203	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisone—psoriasis	7.37e-05	0.000202	CcSEcCtD
Quetiapine—Paraesthesia—Triamcinolone—psoriasis	7.37e-05	0.000202	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisolone—psoriasis	7.35e-05	0.000202	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—psoriasis	7.35e-05	0.000202	CcSEcCtD
Quetiapine—Anaemia—Prednisone—psoriasis	7.34e-05	0.000202	CcSEcCtD
Quetiapine—Shock—Dexamethasone—psoriasis	7.32e-05	0.000201	CcSEcCtD
Quetiapine—Shock—Betamethasone—psoriasis	7.32e-05	0.000201	CcSEcCtD
Quetiapine—Dyspnoea—Triamcinolone—psoriasis	7.31e-05	0.000201	CcSEcCtD
Quetiapine—Nervous system disorder—Betamethasone—psoriasis	7.3e-05	0.0002	CcSEcCtD
Quetiapine—Nervous system disorder—Dexamethasone—psoriasis	7.3e-05	0.0002	CcSEcCtD
Quetiapine—Agitation—Prednisone—psoriasis	7.3e-05	0.0002	CcSEcCtD
Quetiapine—Thrombocytopenia—Dexamethasone—psoriasis	7.29e-05	0.0002	CcSEcCtD
Quetiapine—Thrombocytopenia—Betamethasone—psoriasis	7.29e-05	0.0002	CcSEcCtD
Quetiapine—Tachycardia—Betamethasone—psoriasis	7.26e-05	0.0002	CcSEcCtD
Quetiapine—Tachycardia—Dexamethasone—psoriasis	7.26e-05	0.0002	CcSEcCtD
Quetiapine—Angioedema—Prednisone—psoriasis	7.26e-05	0.000199	CcSEcCtD
Quetiapine—Hypersensitivity—Cyclosporine—psoriasis	7.22e-05	0.000198	CcSEcCtD
Quetiapine—Dyspepsia—Triamcinolone—psoriasis	7.22e-05	0.000198	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—psoriasis	7.21e-05	0.000198	CcSEcCtD
Quetiapine—Nausea—Mycophenolic acid—psoriasis	7.2e-05	0.000198	CcSEcCtD
Quetiapine—Hyperhidrosis—Betamethasone—psoriasis	7.19e-05	0.000198	CcSEcCtD
Quetiapine—Hyperhidrosis—Dexamethasone—psoriasis	7.19e-05	0.000198	CcSEcCtD
Quetiapine—Feeling abnormal—Hydrocortisone—psoriasis	7.18e-05	0.000197	CcSEcCtD
Quetiapine—Malaise—Prednisone—psoriasis	7.16e-05	0.000197	CcSEcCtD
Quetiapine—Vertigo—Prednisone—psoriasis	7.13e-05	0.000196	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—psoriasis	7.12e-05	0.000196	CcSEcCtD
Quetiapine—Gastrointestinal pain—Hydrocortisone—psoriasis	7.12e-05	0.000196	CcSEcCtD
Quetiapine—Syncope—Prednisone—psoriasis	7.12e-05	0.000196	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—psoriasis	7.11e-05	0.000195	CcSEcCtD
Quetiapine—Anorexia—Betamethasone—psoriasis	7.09e-05	0.000195	CcSEcCtD
Quetiapine—Anorexia—Dexamethasone—psoriasis	7.09e-05	0.000195	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—psoriasis	7.08e-05	0.000194	CcSEcCtD
Quetiapine—Fatigue—Triamcinolone—psoriasis	7.07e-05	0.000194	CcSEcCtD
Quetiapine—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.04e-05	0.000194	CcSEcCtD
Quetiapine—Asthenia—Cyclosporine—psoriasis	7.03e-05	0.000193	CcSEcCtD
Quetiapine—Pain—Triamcinolone—psoriasis	7.01e-05	0.000193	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisone—psoriasis	6.98e-05	0.000192	CcSEcCtD
Quetiapine—Hypotension—Betamethasone—psoriasis	6.95e-05	0.000191	CcSEcCtD
Quetiapine—Hypotension—Dexamethasone—psoriasis	6.95e-05	0.000191	CcSEcCtD
Quetiapine—Pruritus—Cyclosporine—psoriasis	6.93e-05	0.00019	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—psoriasis	6.92e-05	0.00019	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—psoriasis	6.89e-05	0.000189	CcSEcCtD
Quetiapine—Abdominal pain—Hydrocortisone—psoriasis	6.89e-05	0.000189	CcSEcCtD
Quetiapine—Body temperature increased—Hydrocortisone—psoriasis	6.89e-05	0.000189	CcSEcCtD
Quetiapine—Convulsion—Prednisone—psoriasis	6.88e-05	0.000189	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—psoriasis	6.87e-05	0.000189	CcSEcCtD
Quetiapine—Asthenia—Mycophenolate mofetil—psoriasis	6.86e-05	0.000188	CcSEcCtD
Quetiapine—Hypertension—Prednisone—psoriasis	6.86e-05	0.000188	CcSEcCtD
Quetiapine—Chills—Methotrexate—psoriasis	6.84e-05	0.000188	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.78e-05	0.000186	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Betamethasone—psoriasis	6.78e-05	0.000186	CcSEcCtD
Quetiapine—Pruritus—Mycophenolate mofetil—psoriasis	6.76e-05	0.000186	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—psoriasis	6.76e-05	0.000186	CcSEcCtD
Quetiapine—Myalgia—Prednisone—psoriasis	6.76e-05	0.000186	CcSEcCtD
Quetiapine—Feeling abnormal—Triamcinolone—psoriasis	6.76e-05	0.000186	CcSEcCtD
Quetiapine—Anxiety—Prednisone—psoriasis	6.74e-05	0.000185	CcSEcCtD
Quetiapine—Insomnia—Betamethasone—psoriasis	6.73e-05	0.000185	CcSEcCtD
Quetiapine—Insomnia—Dexamethasone—psoriasis	6.73e-05	0.000185	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.71e-05	0.000184	CcSEcCtD
Quetiapine—Diarrhoea—Cyclosporine—psoriasis	6.71e-05	0.000184	CcSEcCtD
Quetiapine—Paraesthesia—Dexamethasone—psoriasis	6.68e-05	0.000184	CcSEcCtD
Quetiapine—Paraesthesia—Betamethasone—psoriasis	6.68e-05	0.000184	CcSEcCtD
Quetiapine—Discomfort—Prednisone—psoriasis	6.68e-05	0.000184	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—psoriasis	6.68e-05	0.000183	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—psoriasis	6.64e-05	0.000182	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisolone—psoriasis	6.57e-05	0.000181	CcSEcCtD
Quetiapine—Dyspepsia—Dexamethasone—psoriasis	6.55e-05	0.00018	CcSEcCtD
Quetiapine—Dyspepsia—Betamethasone—psoriasis	6.55e-05	0.00018	CcSEcCtD
Quetiapine—Diarrhoea—Mycophenolate mofetil—psoriasis	6.54e-05	0.00018	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—psoriasis	6.5e-05	0.000179	CcSEcCtD
Quetiapine—Body temperature increased—Triamcinolone—psoriasis	6.48e-05	0.000178	CcSEcCtD
Quetiapine—Dizziness—Cyclosporine—psoriasis	6.48e-05	0.000178	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisone—psoriasis	6.48e-05	0.000178	CcSEcCtD
Quetiapine—Decreased appetite—Betamethasone—psoriasis	6.47e-05	0.000178	CcSEcCtD
Quetiapine—Decreased appetite—Dexamethasone—psoriasis	6.47e-05	0.000178	CcSEcCtD
Quetiapine—Infection—Prednisone—psoriasis	6.44e-05	0.000177	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Dexamethasone—psoriasis	6.43e-05	0.000177	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Betamethasone—psoriasis	6.43e-05	0.000177	CcSEcCtD
Quetiapine—Back pain—Methotrexate—psoriasis	6.42e-05	0.000176	CcSEcCtD
Quetiapine—Hypersensitivity—Hydrocortisone—psoriasis	6.42e-05	0.000176	CcSEcCtD
Quetiapine—Fatigue—Dexamethasone—psoriasis	6.42e-05	0.000176	CcSEcCtD
Quetiapine—Fatigue—Betamethasone—psoriasis	6.42e-05	0.000176	CcSEcCtD
Quetiapine—Shock—Prednisone—psoriasis	6.38e-05	0.000175	CcSEcCtD
Quetiapine—Pain—Dexamethasone—psoriasis	6.36e-05	0.000175	CcSEcCtD
Quetiapine—Pain—Betamethasone—psoriasis	6.36e-05	0.000175	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—psoriasis	6.36e-05	0.000175	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—psoriasis	6.33e-05	0.000174	CcSEcCtD
Quetiapine—Dizziness—Mycophenolate mofetil—psoriasis	6.32e-05	0.000174	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—psoriasis	6.3e-05	0.000173	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—psoriasis	6.27e-05	0.000172	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—psoriasis	6.25e-05	0.000172	CcSEcCtD
Quetiapine—Asthenia—Hydrocortisone—psoriasis	6.25e-05	0.000172	CcSEcCtD
Quetiapine—Vomiting—Cyclosporine—psoriasis	6.23e-05	0.000171	CcSEcCtD
Quetiapine—Rash—Cyclosporine—psoriasis	6.18e-05	0.00017	CcSEcCtD
Quetiapine—Anorexia—Prednisone—psoriasis	6.18e-05	0.00017	CcSEcCtD
Quetiapine—Dermatitis—Cyclosporine—psoriasis	6.17e-05	0.00017	CcSEcCtD
Quetiapine—Pruritus—Hydrocortisone—psoriasis	6.16e-05	0.000169	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—psoriasis	6.16e-05	0.000169	CcSEcCtD
Quetiapine—Headache—Cyclosporine—psoriasis	6.14e-05	0.000169	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—psoriasis	6.13e-05	0.000169	CcSEcCtD
Quetiapine—Feeling abnormal—Betamethasone—psoriasis	6.13e-05	0.000168	CcSEcCtD
Quetiapine—Feeling abnormal—Dexamethasone—psoriasis	6.13e-05	0.000168	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dexamethasone—psoriasis	6.09e-05	0.000167	CcSEcCtD
Quetiapine—Gastrointestinal pain—Betamethasone—psoriasis	6.09e-05	0.000167	CcSEcCtD
Quetiapine—Vomiting—Mycophenolate mofetil—psoriasis	6.08e-05	0.000167	CcSEcCtD
Quetiapine—Hypersensitivity—Triamcinolone—psoriasis	6.04e-05	0.000166	CcSEcCtD
Quetiapine—Rash—Mycophenolate mofetil—psoriasis	6.03e-05	0.000166	CcSEcCtD
Quetiapine—Dermatitis—Mycophenolate mofetil—psoriasis	6.02e-05	0.000165	CcSEcCtD
Quetiapine—Headache—Mycophenolate mofetil—psoriasis	5.99e-05	0.000165	CcSEcCtD
Quetiapine—Malaise—Methotrexate—psoriasis	5.99e-05	0.000164	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—psoriasis	5.96e-05	0.000164	CcSEcCtD
Quetiapine—Diarrhoea—Hydrocortisone—psoriasis	5.96e-05	0.000164	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—psoriasis	5.94e-05	0.000163	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—psoriasis	5.9e-05	0.000162	CcSEcCtD
Quetiapine—Dizziness—Prednisolone—psoriasis	5.9e-05	0.000162	CcSEcCtD
Quetiapine—Asthenia—Triamcinolone—psoriasis	5.88e-05	0.000162	CcSEcCtD
Quetiapine—Abdominal pain—Betamethasone—psoriasis	5.88e-05	0.000162	CcSEcCtD
Quetiapine—Abdominal pain—Dexamethasone—psoriasis	5.88e-05	0.000162	CcSEcCtD
Quetiapine—Body temperature increased—Dexamethasone—psoriasis	5.88e-05	0.000162	CcSEcCtD
Quetiapine—Body temperature increased—Betamethasone—psoriasis	5.88e-05	0.000162	CcSEcCtD
Quetiapine—Insomnia—Prednisone—psoriasis	5.86e-05	0.000161	CcSEcCtD
Quetiapine—Nausea—Cyclosporine—psoriasis	5.82e-05	0.00016	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—psoriasis	5.82e-05	0.00016	CcSEcCtD
Quetiapine—Pruritus—Triamcinolone—psoriasis	5.8e-05	0.000159	CcSEcCtD
Quetiapine—Cough—Methotrexate—psoriasis	5.79e-05	0.000159	CcSEcCtD
Quetiapine—Dizziness—Hydrocortisone—psoriasis	5.76e-05	0.000158	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—psoriasis	5.75e-05	0.000158	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—psoriasis	5.71e-05	0.000157	CcSEcCtD
Quetiapine—Nausea—Mycophenolate mofetil—psoriasis	5.68e-05	0.000156	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—psoriasis	5.65e-05	0.000155	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—psoriasis	5.65e-05	0.000155	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—psoriasis	5.65e-05	0.000155	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—psoriasis	5.63e-05	0.000155	CcSEcCtD
Quetiapine—Rash—Prednisolone—psoriasis	5.62e-05	0.000154	CcSEcCtD
Quetiapine—Dermatitis—Prednisolone—psoriasis	5.62e-05	0.000154	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.61e-05	0.000154	CcSEcCtD
Quetiapine—Fatigue—Prednisone—psoriasis	5.59e-05	0.000154	CcSEcCtD
Quetiapine—Headache—Prednisolone—psoriasis	5.59e-05	0.000153	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—psoriasis	5.58e-05	0.000153	CcSEcCtD
Quetiapine—Constipation—Prednisone—psoriasis	5.54e-05	0.000152	CcSEcCtD
Quetiapine—Vomiting—Hydrocortisone—psoriasis	5.54e-05	0.000152	CcSEcCtD
Quetiapine—Rash—Hydrocortisone—psoriasis	5.49e-05	0.000151	CcSEcCtD
Quetiapine—Dermatitis—Hydrocortisone—psoriasis	5.49e-05	0.000151	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—psoriasis	5.46e-05	0.00015	CcSEcCtD
Quetiapine—Headache—Hydrocortisone—psoriasis	5.46e-05	0.00015	CcSEcCtD
Quetiapine—Dizziness—Triamcinolone—psoriasis	5.42e-05	0.000149	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—psoriasis	5.42e-05	0.000149	CcSEcCtD
Quetiapine—Infection—Methotrexate—psoriasis	5.38e-05	0.000148	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—psoriasis	5.34e-05	0.000147	CcSEcCtD
Quetiapine—Asthenia—Betamethasone—psoriasis	5.34e-05	0.000147	CcSEcCtD
Quetiapine—Asthenia—Dexamethasone—psoriasis	5.34e-05	0.000147	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—psoriasis	5.31e-05	0.000146	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—psoriasis	5.3e-05	0.000146	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—psoriasis	5.3e-05	0.000146	CcSEcCtD
Quetiapine—Nausea—Prednisolone—psoriasis	5.3e-05	0.000146	CcSEcCtD
Quetiapine—Pruritus—Betamethasone—psoriasis	5.27e-05	0.000145	CcSEcCtD
Quetiapine—Pruritus—Dexamethasone—psoriasis	5.27e-05	0.000145	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—psoriasis	5.26e-05	0.000145	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—psoriasis	5.24e-05	0.000144	CcSEcCtD
Quetiapine—Vomiting—Triamcinolone—psoriasis	5.22e-05	0.000143	CcSEcCtD
Quetiapine—Nausea—Hydrocortisone—psoriasis	5.17e-05	0.000142	CcSEcCtD
Quetiapine—Rash—Triamcinolone—psoriasis	5.17e-05	0.000142	CcSEcCtD
Quetiapine—Dermatitis—Triamcinolone—psoriasis	5.17e-05	0.000142	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—psoriasis	5.16e-05	0.000142	CcSEcCtD
Quetiapine—Headache—Triamcinolone—psoriasis	5.14e-05	0.000141	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—psoriasis	5.12e-05	0.000141	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—psoriasis	5.12e-05	0.000141	CcSEcCtD
Quetiapine—Diarrhoea—Dexamethasone—psoriasis	5.09e-05	0.00014	CcSEcCtD
Quetiapine—Diarrhoea—Betamethasone—psoriasis	5.09e-05	0.00014	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—psoriasis	5.06e-05	0.000139	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—psoriasis	4.93e-05	0.000136	CcSEcCtD
Quetiapine—Dizziness—Dexamethasone—psoriasis	4.92e-05	0.000135	CcSEcCtD
Quetiapine—Dizziness—Betamethasone—psoriasis	4.92e-05	0.000135	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—psoriasis	4.9e-05	0.000135	CcSEcCtD
Quetiapine—Nausea—Triamcinolone—psoriasis	4.87e-05	0.000134	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—psoriasis	4.86e-05	0.000134	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—psoriasis	4.83e-05	0.000133	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—psoriasis	4.82e-05	0.000132	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—psoriasis	4.78e-05	0.000131	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—psoriasis	4.77e-05	0.000131	CcSEcCtD
Quetiapine—Vomiting—Dexamethasone—psoriasis	4.73e-05	0.00013	CcSEcCtD
Quetiapine—Vomiting—Betamethasone—psoriasis	4.73e-05	0.00013	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—psoriasis	4.71e-05	0.000129	CcSEcCtD
Quetiapine—Rash—Betamethasone—psoriasis	4.69e-05	0.000129	CcSEcCtD
Quetiapine—Rash—Dexamethasone—psoriasis	4.69e-05	0.000129	CcSEcCtD
Quetiapine—Dermatitis—Betamethasone—psoriasis	4.69e-05	0.000129	CcSEcCtD
Quetiapine—Dermatitis—Dexamethasone—psoriasis	4.69e-05	0.000129	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—psoriasis	4.68e-05	0.000128	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—psoriasis	4.67e-05	0.000128	CcSEcCtD
Quetiapine—Headache—Dexamethasone—psoriasis	4.66e-05	0.000128	CcSEcCtD
Quetiapine—Headache—Betamethasone—psoriasis	4.66e-05	0.000128	CcSEcCtD
Quetiapine—Asthenia—Prednisone—psoriasis	4.65e-05	0.000128	CcSEcCtD
Quetiapine—Pain—Methotrexate—psoriasis	4.63e-05	0.000127	CcSEcCtD
Quetiapine—Pruritus—Prednisone—psoriasis	4.59e-05	0.000126	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—psoriasis	4.46e-05	0.000123	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—psoriasis	4.43e-05	0.000122	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—psoriasis	4.43e-05	0.000122	CcSEcCtD
Quetiapine—Nausea—Dexamethasone—psoriasis	4.42e-05	0.000121	CcSEcCtD
Quetiapine—Nausea—Betamethasone—psoriasis	4.42e-05	0.000121	CcSEcCtD
Quetiapine—Dizziness—Prednisone—psoriasis	4.29e-05	0.000118	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—psoriasis	4.28e-05	0.000118	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—psoriasis	4.28e-05	0.000118	CcSEcCtD
Quetiapine—Vomiting—Prednisone—psoriasis	4.12e-05	0.000113	CcSEcCtD
Quetiapine—Rash—Prednisone—psoriasis	4.09e-05	0.000112	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—psoriasis	4.08e-05	0.000112	CcSEcCtD
Quetiapine—Headache—Prednisone—psoriasis	4.06e-05	0.000112	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—psoriasis	3.99e-05	0.00011	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—psoriasis	3.89e-05	0.000107	CcSEcCtD
Quetiapine—Nausea—Prednisone—psoriasis	3.85e-05	0.000106	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—psoriasis	3.83e-05	0.000105	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—psoriasis	3.71e-05	0.000102	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—psoriasis	3.58e-05	9.84e-05	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—psoriasis	3.44e-05	9.46e-05	CcSEcCtD
Quetiapine—Rash—Methotrexate—psoriasis	3.42e-05	9.38e-05	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—psoriasis	3.41e-05	9.37e-05	CcSEcCtD
Quetiapine—Headache—Methotrexate—psoriasis	3.39e-05	9.32e-05	CcSEcCtD
Quetiapine—Nausea—Methotrexate—psoriasis	3.22e-05	8.84e-05	CcSEcCtD
Quetiapine—CHRM5—Signaling Pathways—TYK2—psoriasis	8.47e-06	0.000127	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	8.43e-06	0.000126	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	8.2e-06	0.000123	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CXCL8—psoriasis	8.16e-06	0.000122	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CXCL8—psoriasis	8.15e-06	0.000122	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PPARG—psoriasis	8.11e-06	0.000122	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CXCL8—psoriasis	8.1e-06	0.000121	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TYK2—psoriasis	8.07e-06	0.000121	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	8.07e-06	0.000121	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	8.04e-06	0.000121	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—LEP—psoriasis	7.98e-06	0.00012	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—APOE—psoriasis	7.98e-06	0.00012	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TYK2—psoriasis	7.96e-06	0.000119	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TYK2—psoriasis	7.96e-06	0.000119	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CXCL8—psoriasis	7.93e-06	0.000119	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—LEP—psoriasis	7.85e-06	0.000118	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—APOE—psoriasis	7.85e-06	0.000118	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—APOE—psoriasis	7.83e-06	0.000118	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—LEP—psoriasis	7.83e-06	0.000118	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—APOE—psoriasis	7.83e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—LEP—psoriasis	7.81e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—APOE—psoriasis	7.81e-06	0.000117	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CXCL8—psoriasis	7.8e-06	0.000117	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CAT—psoriasis	7.79e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—LEP—psoriasis	7.78e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—APOE—psoriasis	7.78e-06	0.000117	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL6—psoriasis	7.76e-06	0.000116	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL6—psoriasis	7.75e-06	0.000116	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—APOE—psoriasis	7.71e-06	0.000116	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—LEP—psoriasis	7.71e-06	0.000116	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL6—psoriasis	7.7e-06	0.000115	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CXCL8—psoriasis	7.7e-06	0.000115	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—LEP—psoriasis	7.69e-06	0.000115	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—APOE—psoriasis	7.69e-06	0.000115	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CARM1—psoriasis	7.62e-06	0.000114	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CAT—psoriasis	7.6e-06	0.000114	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—JUN—psoriasis	7.59e-06	0.000114	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—JUN—psoriasis	7.58e-06	0.000114	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—psoriasis	7.54e-06	0.000113	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—JUN—psoriasis	7.53e-06	0.000113	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PPARG—psoriasis	7.44e-06	0.000112	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NFKBIA—psoriasis	7.44e-06	0.000112	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—psoriasis	7.42e-06	0.000111	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CXCL8—psoriasis	7.37e-06	0.000111	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—JUN—psoriasis	7.37e-06	0.000111	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—psoriasis	7.33e-06	0.00011	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—psoriasis	7.32e-06	0.00011	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	7.32e-06	0.00011	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—NFKB1—psoriasis	7.3e-06	0.00011	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NFKBIA—psoriasis	7.3e-06	0.00011	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—NFKB1—psoriasis	7.29e-06	0.000109	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	7.28e-06	0.000109	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	7.25e-06	0.000109	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—JUN—psoriasis	7.25e-06	0.000109	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—NFKB1—psoriasis	7.25e-06	0.000109	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TYK2—psoriasis	7.19e-06	0.000108	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	7.18e-06	0.000108	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CAT—psoriasis	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—JUN—psoriasis	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—LEP—psoriasis	7.14e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—APOE—psoriasis	7.14e-06	0.000107	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—NFKB1—psoriasis	7.1e-06	0.000106	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CXCL8—psoriasis	7.02e-06	0.000105	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—psoriasis	7.01e-06	0.000105	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—NFKB1—psoriasis	6.98e-06	0.000105	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TYK2—psoriasis	6.94e-06	0.000104	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CXCL8—psoriasis	6.93e-06	0.000104	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	6.93e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TYK2—psoriasis	6.9e-06	0.000104	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—NFKB1—psoriasis	6.89e-06	0.000103	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—JUN—psoriasis	6.85e-06	0.000103	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PPARG—psoriasis	6.82e-06	0.000102	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TYK2—psoriasis	6.71e-06	0.000101	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—psoriasis	6.71e-06	0.000101	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—psoriasis	6.68e-06	0.0001	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	6.66e-06	9.98e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—VEGFA—psoriasis	6.63e-06	9.94e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—VEGFA—psoriasis	6.62e-06	9.93e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TYK2—psoriasis	6.61e-06	9.91e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—NFKB1—psoriasis	6.6e-06	9.89e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—psoriasis	6.59e-06	9.88e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—psoriasis	6.59e-06	9.88e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—VEGFA—psoriasis	6.58e-06	9.86e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—STAT3—psoriasis	6.56e-06	9.84e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—STAT3—psoriasis	6.55e-06	9.83e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—JUN—psoriasis	6.53e-06	9.79e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—STAT3—psoriasis	6.51e-06	9.77e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—psoriasis	6.49e-06	9.73e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—JUN—psoriasis	6.44e-06	9.66e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—JUN—psoriasis	6.44e-06	9.66e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—VEGFA—psoriasis	6.44e-06	9.66e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—STAT3—psoriasis	6.38e-06	9.56e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—VEGFA—psoriasis	6.34e-06	9.5e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—NFKB1—psoriasis	6.29e-06	9.43e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—STAT3—psoriasis	6.27e-06	9.41e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	6.26e-06	9.38e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—VEGFA—psoriasis	6.25e-06	9.38e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—NFKB1—psoriasis	6.2e-06	9.3e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	6.2e-06	9.3e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—STAT3—psoriasis	6.19e-06	9.28e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TYK2—psoriasis	6.09e-06	9.13e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—APOE—psoriasis	6.05e-06	9.08e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCL8—psoriasis	6.04e-06	9.06e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.01e-06	9.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TYK2—psoriasis	5.99e-06	8.99e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—VEGFA—psoriasis	5.99e-06	8.98e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TYK2—psoriasis	5.98e-06	8.97e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TYK2—psoriasis	5.96e-06	8.94e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—psoriasis	5.95e-06	8.92e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TYK2—psoriasis	5.94e-06	8.91e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—psoriasis	5.94e-06	8.91e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—STAT3—psoriasis	5.93e-06	8.89e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—APOE—psoriasis	5.91e-06	8.86e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TYK2—psoriasis	5.88e-06	8.83e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TYK2—psoriasis	5.87e-06	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	5.84e-06	8.77e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—JUN—psoriasis	5.82e-06	8.72e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	5.75e-06	8.63e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—psoriasis	5.74e-06	8.61e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—psoriasis	5.71e-06	8.57e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—psoriasis	5.7e-06	8.56e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STAT3—psoriasis	5.65e-06	8.47e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—psoriasis	5.63e-06	8.44e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	5.63e-06	8.44e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—JUN—psoriasis	5.62e-06	8.42e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	5.6e-06	8.4e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—JUN—psoriasis	5.59e-06	8.38e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STAT3—psoriasis	5.57e-06	8.36e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STAT3—psoriasis	5.57e-06	8.36e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—psoriasis	5.57e-06	8.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—psoriasis	5.56e-06	8.34e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—psoriasis	5.47e-06	8.2e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TYK2—psoriasis	5.45e-06	8.18e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—JUN—psoriasis	5.43e-06	8.15e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NFKB1—psoriasis	5.41e-06	8.11e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.38e-06	8.06e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—JUN—psoriasis	5.35e-06	8.02e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—psoriasis	5.3e-06	7.95e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—psoriasis	5.27e-06	7.91e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	5.23e-06	7.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.22e-06	7.83e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—psoriasis	5.21e-06	7.81e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—psoriasis	5.19e-06	7.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—psoriasis	5.17e-06	7.76e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	5.15e-06	7.72e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—psoriasis	5.15e-06	7.72e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—psoriasis	5.12e-06	7.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.11e-06	7.66e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	5.08e-06	7.62e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—psoriasis	5.04e-06	7.56e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—psoriasis	5.03e-06	7.55e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—psoriasis	5.01e-06	7.51e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—psoriasis	5e-06	7.5e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—psoriasis	4.97e-06	7.45e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—psoriasis	4.96e-06	7.44e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—psoriasis	4.95e-06	7.43e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—psoriasis	4.94e-06	7.4e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—JUN—psoriasis	4.93e-06	7.39e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—psoriasis	4.92e-06	7.38e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—psoriasis	4.91e-06	7.36e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—psoriasis	4.88e-06	7.32e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—psoriasis	4.87e-06	7.31e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—psoriasis	4.87e-06	7.3e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—psoriasis	4.86e-06	7.29e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—psoriasis	4.86e-06	7.28e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—JUN—psoriasis	4.85e-06	7.28e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—psoriasis	4.85e-06	7.27e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—JUN—psoriasis	4.84e-06	7.26e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—psoriasis	4.83e-06	7.25e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—JUN—psoriasis	4.82e-06	7.24e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—JUN—psoriasis	4.81e-06	7.21e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—psoriasis	4.79e-06	7.18e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—JUN—psoriasis	4.76e-06	7.14e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—JUN—psoriasis	4.75e-06	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	4.75e-06	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	4.75e-06	7.12e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NFKB1—psoriasis	4.75e-06	7.12e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—psoriasis	4.72e-06	7.08e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—psoriasis	4.7e-06	7.05e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAT—psoriasis	4.68e-06	7.03e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	4.67e-06	7.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NFKB1—psoriasis	4.67e-06	7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NFKB1—psoriasis	4.66e-06	6.99e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NFKB1—psoriasis	4.64e-06	6.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NFKB1—psoriasis	4.63e-06	6.94e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—psoriasis	4.63e-06	6.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKB1—psoriasis	4.58e-06	6.88e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—psoriasis	4.58e-06	6.87e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—psoriasis	4.58e-06	6.87e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.57e-06	6.86e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—psoriasis	4.55e-06	6.82e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—psoriasis	4.52e-06	6.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—psoriasis	4.51e-06	6.77e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—psoriasis	4.45e-06	6.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—psoriasis	4.41e-06	6.62e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—psoriasis	4.38e-06	6.57e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—psoriasis	4.32e-06	6.48e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—psoriasis	4.31e-06	6.46e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—psoriasis	4.31e-06	6.46e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—psoriasis	4.26e-06	6.4e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—psoriasis	4.25e-06	6.38e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—psoriasis	4.25e-06	6.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	4.25e-06	6.37e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.24e-06	6.36e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—psoriasis	4.23e-06	6.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—psoriasis	4.22e-06	6.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—psoriasis	4.2e-06	6.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—psoriasis	4.2e-06	6.29e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—psoriasis	4.19e-06	6.28e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—psoriasis	4.17e-06	6.26e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—psoriasis	4.16e-06	6.24e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—psoriasis	4.16e-06	6.24e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.15e-06	6.22e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—psoriasis	4.14e-06	6.21e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—psoriasis	4.12e-06	6.18e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.11e-06	6.16e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—psoriasis	3.95e-06	5.92e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—psoriasis	3.89e-06	5.84e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—psoriasis	3.89e-06	5.84e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	3.86e-06	5.78e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—psoriasis	3.84e-06	5.76e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—psoriasis	3.82e-06	5.73e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—psoriasis	3.71e-06	5.56e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—psoriasis	3.69e-06	5.53e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—psoriasis	3.64e-06	5.46e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—psoriasis	3.59e-06	5.38e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—psoriasis	3.53e-06	5.29e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—psoriasis	3.51e-06	5.27e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—psoriasis	3.39e-06	5.09e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—psoriasis	3.38e-06	5.06e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—psoriasis	3.28e-06	4.92e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—psoriasis	3.25e-06	4.88e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.23e-06	4.85e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—psoriasis	3.2e-06	4.8e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—psoriasis	3.2e-06	4.79e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—psoriasis	3.19e-06	4.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—psoriasis	3.17e-06	4.76e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—psoriasis	3.17e-06	4.75e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—psoriasis	3.14e-06	4.72e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.14e-06	4.7e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—psoriasis	2.98e-06	4.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—psoriasis	2.93e-06	4.4e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—psoriasis	2.92e-06	4.39e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—psoriasis	2.92e-06	4.37e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—psoriasis	2.91e-06	4.37e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—psoriasis	2.91e-06	4.36e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—psoriasis	2.88e-06	4.32e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—psoriasis	2.87e-06	4.3e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—psoriasis	2.67e-06	4e-05	CbGpPWpGaD
